Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease-Reference-Cited by-同舟云学术

Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease

Published:2001-10 Issue:1 Volume:115 Page:79-83
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Berentsen Sigbjørn,Tjønnfjord Geir E.,Brudevold Robert,Gjertsen Bjørn T.,Langholm Ruth,Løkkevik Erik,Sørbø Jon Hjalmar,Ulvestad Elling

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2001.03078.x/fullpdf

Reference24 articles.

1. Chronic cold agglutinin disease of the ‘idiopathic’ type is a premalignant or low-grade malignant lymphoproliferative disease;Berentsen;APMIS,1997

2. No response to cladribine in five patients with chronic cold agglutinin disease;Berentsen;European Journal of Haematology,2000

3. B-cell neoplasms with homogenous cold-reacting antibodies (cold agglutinins);Crisp;American Journal of Medicine,1982

4. Dacie , J. 1992a Auto-immune haemolytic anaemia (AIHA): cold antibody syndromes I: idiopathic types: clinical presentation and haematological and serological findings The Haemolytic Anaemias J. Dacie 3rd edn 3 210 239 Churchill Livingstone

5. Dacie , J. 1992b Treatment and prognosis of cold-antibody AIHA The Haemolytic Anaemias J. Dacie 3rd edn 3 502 508 Churchill Livingstone

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of sutimlimab for cold agglutinin disease in a patient on chronic hemodialysis;CEN Case Reports;2024-07-17

2. Cutaneous Reactions to Cold and Heat;Rook's Textbook of Dermatology;2024-03-19

3. Autoimmune hemolytic anemia: the current state of the issue;Oncohematology;2023-05-28

4. Monoclonal antibodies for treatment of cold agglutinin disease;Expert Opinion on Biological Therapy;2023-05-04

5. Practical therapy for primary autoimmune hemolytic anemia in adults;Clinical and Experimental Medicine;2022-08-18